ZEB1 and lung adenocarcinoma: Consistent with these findings, we showed that the proteasome inhibitor MG132, but not the lysosome inhibitor CQ, significantly suppressed the degradation of ZEB1 protein by Biochanin A treatment in lung adenocarcinoma cells, demonstrating the ubiquitination-mediated protein stability is involved in this process.